197 related articles for article (PubMed ID: 11818533)
1. Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis.
Napoli C; Aldini G; Wallace JL; de Nigris F; Maffei R; Abete P; Bonaduce D; Condorelli G; Rengo F; Sica V; D'Armiento FP; Mignogna C; de Rosa G; Condorelli M; Lerman LO; Ignarro LJ
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1689-94. PubMed ID: 11818533
[TBL] [Abstract][Full Text] [Related]
2. Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice.
Napoli C; Cirino G; Del Soldato P; Sorrentino R; Sica V; Condorelli M; Pinto A; Ignarro LJ
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2860-4. PubMed ID: 11226331
[TBL] [Abstract][Full Text] [Related]
3. Intimal hyperplasia in balloon dilated coronary arteries is reduced by local delivery of the NO donor, SIN-1 via a cGMP-dependent pathway.
Harnek J; Zoucas E; de Sá VP; Ekblad E; Arner A; Stenram U
BMC Cardiovasc Disord; 2011 Jun; 11():30. PubMed ID: 21663688
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of NO-releasing derivative of flurbiprofen (HCT-1026) in rat model of vascular injury and restenosis.
Maffia P; Ianaro A; Sorrentino R; Lippolis L; Maiello FM; del Soldato P; Ialenti A; Cirino G
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):263-7. PubMed ID: 11834526
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine (SIN-1).
Wan S; Shukla N; Angelini GD; Yim AP; Johnson JL; Jeremy JY
J Thorac Cardiovasc Surg; 2007 Oct; 134(4):1033-9. PubMed ID: 17903525
[TBL] [Abstract][Full Text] [Related]
6. Avβ3 single-stranded DNA aptamer attenuates vascular restenosis via Ras-PI3K/MAPK pathway in rats after percutaneous transluminal coronary angioplasty.
Wu HB; Wang ZW; Shi F; Ren ZL; Li LC; Hu XP; Hu R; Li BW
Artif Organs; 2020 Jun; 44(6):611-619. PubMed ID: 31879964
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-releasing aspirin inhibits vasoconstriction in perfused tail artery of normotensive and spontaneously hypertensive rats.
Rossoni G; Manfredi B; Del Soldato P; Polvani G; Berti F
Eur J Pharmacol; 2003 Sep; 477(1):59-68. PubMed ID: 14512099
[TBL] [Abstract][Full Text] [Related]
8. Lack of gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in the stomach of diabetic rats.
Tashima K; Fujita A; Umeda M; Takeuchi K
Life Sci; 2000 Aug; 67(13):1639-52. PubMed ID: 10983857
[TBL] [Abstract][Full Text] [Related]
9. Low gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in rats with cirrhosis and arthritis.
Kato S; Suzuki K; Ukawa H; Komoike Y; Takeuchi K
Dig Dis Sci; 2001 Aug; 46(8):1690-9. PubMed ID: 11508669
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia.
Kapadia MR; Chow LW; Tsihlis ND; Ahanchi SS; Eng JW; Murar J; Martinez J; Popowich DA; Jiang Q; Hrabie JA; Saavedra JE; Keefer LK; Hulvat JF; Stupp SI; Kibbe MR
J Vasc Surg; 2008 Jan; 47(1):173-82. PubMed ID: 18178471
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
[TBL] [Abstract][Full Text] [Related]
12. Coronary artery in-stent stenosis persists despite inhibition of the von Willebrand factor--collagen interaction in baboons.
De Meyer SF; Staelens S; Badenhorst PN; Pieters H; Lamprecht S; Roodt J; Janssens S; Meiring M; Vanhoorelbeke K; Bruwer A; Brown S; Deckmyn H
Thromb Haemost; 2007 Dec; 98(6):1343-9. PubMed ID: 18064334
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
[TBL] [Abstract][Full Text] [Related]
14. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.
Wallace JL; McKnight W; Del Soldato P; Baydoun AR; Cirino G
J Clin Invest; 1995 Dec; 96(6):2711-8. PubMed ID: 8675638
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide-releasing aspirin derivative, NCX 4016, promotes reparative angiogenesis and prevents apoptosis and oxidative stress in a mouse model of peripheral ischemia.
Emanueli C; Van Linthout S; Salis MB; Monopoli A; Del Soldato P; Ongini E; Madeddu P
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2082-7. PubMed ID: 15345513
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats.
Fiorucci S; Antonelli E; Santucci L; Morelli O; Miglietti M; Federici B; Mannucci R; Del Soldato P; Morelli A
Gastroenterology; 1999 May; 116(5):1089-106. PubMed ID: 10220501
[TBL] [Abstract][Full Text] [Related]
17. Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries.
Anderson HV; McNatt J; Clubb FJ; Herman M; Maffrand JP; DeClerck F; Ahn C; Buja LM; Willerson JT
Circulation; 2001 Nov; 104(19):2331-7. PubMed ID: 11696474
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders.
Gresele P; Momi S
Cardiovasc Drug Rev; 2006; 24(2):148-68. PubMed ID: 16961726
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of restenosis after coronary intervention: difference between plain old balloon angioplasty and stenting.
Nakatani M; Takeyama Y; Shibata M; Yorozuya M; Suzuki H; Koba S; Katagiri T
Cardiovasc Pathol; 2003; 12(1):40-8. PubMed ID: 12598017
[TBL] [Abstract][Full Text] [Related]
20. The effect of aspirin and two nitric oxide donors on the infarcted heart in situ.
Yamamoto T; Kakar NR; Vina ER; Johnson PE; Bing RJ
Life Sci; 2000 Jul; 67(7):839-46. PubMed ID: 10968413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
